Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 4, 2006, Pages 153-159

  Ziegler, Dan ^a   Zentai, C ^a   Perz, S ^b   Rathmann, W ^a   Haastert, B ^a   Meisinger, C ^b   Lowel H ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cardiovascular risk; Diabetes; Hypertension; Neuropathy; Obesity

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; HEALTH SURVEY; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QT DISPERSION; QT PROLONGATION;

AGED; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 33744924206     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924083     Document Type: Article

References (49)

1. Antelmi I, de Paula RS, Shinzato AR, Peres CA, Mansur AJ, Grupi CJ. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol 2004; 93: 381-385
2. Bazett HC. An analysis of the time-relations of electrocardiogram. Heart 1920; 7: 353-370
3. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 2001; 8: 227-233
4. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study, 1987-1998. Circul 2003a; 107: 2190-2195
5. Carnethon MR, Jacobs DR Jr, Sidney S, Liu K. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care 2003 b; 26: 3035-3041
6. Carnethon MR, Liao D, Evans GW, Cascio WE, Chambless LE, Heiss G. Correlates of the shift in heart rate variability with an active postural change in a healthy population sample: the Atherosclerosis Risk in Communities Study. Am Heart J 2002; 143: 808-813
7. Chen A, Kusumoto FM. QT dispersion: much ado about something? Chest 2004; 125: 1974-1977
8. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circul 1998; 97: 467-472
9. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J 1999; 20: 278-284
10. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 1997; 145: 899-908
11. Emdin M, Gastaldelli A, Muscelli E, Macerata A, Natali A, Camastra S, Ferrannini E. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circul 2001; 103: 513-519
12. Festa A, D'Agostino R Jr, Rautaharju P, Mykkanen L, Haffner SM. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 2000; 86: 1117-1122
13. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289: 187-193
14. Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand 1920; 53: 469-486
15. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circul 2004; 27: 433-438
16. Hense HW, Filipiak B, Döring A et al. Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany: results from the 1984/85, 1989/90 and 1994/1995 surveys. Cardiovasc Dis Prev 1998; 1: 318-327
17. Karjalainen J, Reunanen A, Ristola P, Viitasalo M. QT interval as a cardiac risk factor in a middle aged population. Heart 1997; 77: 543-548
18. Keil U, Cairns V, Döring A et al. MONICA-Project, Region Augsburg. Manual of Operations, Survey. GSF-Bericht 20. Munich: GSF-Forschungszentrum, 1985
19. Kreier F, Yilmaz A, Kalsbeek A, Romijn JA, Sauerwein HP, Fliers E, Buijs RM. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. Diabetes 2003; 52: 2652-2656
20. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Despres JP. Total cholesterol/HDL cholesterol ratio vs. LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001; 161: 2685-2692
21. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, Cai J, Sharrett AR. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998; 21: 2116-2122
22. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circul 2004; 110: 1245-1250
23. Manttari M, Oikarinen L, Manninen V, Viitasalo M. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart 1997; 78: 268-272
24. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26: 1895-1901
25. Meisinger C, Thorand B, Schneider A et al. Gender differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg Cohort Study. Arch Intern Med 2002; 162: 82-89
26. Okin PM, Devereux RB, Lee ET, Galloway JM, Howard BV. Strong Heart Study. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the Strong Heart Study. Diabetes 2004; 53: 434-440
27. Perz S, Pöppl SJ, Stieber J. ECG data management and analysis in the MONICA Survey Augsburg. In: Reichertz PL, Lindberg DAB (eds). Lecture Notes in Medical Informatics 25, Medical Informatics Europe 1985. Heidelberg: Springer, 1985: 811
28. Pshenichnikov I, Shipilova T, Kaik J, Volozh O, Abina J, Lass J, Karai D. QT dispersion in relation to left ventricular geometry and hypertension in a population study. Scand Cardiovasc J 2003; 37: 87-90
29. Quilliot D, Fluckiger L, Zannad F, Drouin P, Ziegler O. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance. Clin Auton Res 2001; 11: 79-86
30. Rabbia F, Silke B, Conterno A, Grosso T, De Vito B, Rabbone I, Chiandussi L, Veglio F. Assessment of cardiac autonomic modulation during adolescent obesity. Obes Res 2003; 11: 541-548
31. Rana BS, Lim PO, Naas AA, Ogston SA, Newton RW, Jung RT, Morris AD, Struthers AD. QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests. Heart 2005; 91: 44-50
32. Sagie A, Larson MG, Goldberg RJ, Bengtson JR, Levy D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992; 70: 797-801
33. Salles GF, Deccache W, Cardoso CR. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension. J Hum Hypertens 2005; 19: 241-249
34. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2005; 28: 668-674
35. Stevens J, Cai J, Juhaeri J, Thun MJ, Williamson DF, Wood JL. Consequences of the use of different measures of effect to determine the impact of age on the association between obesity and mortality. Am J Epidemiol 1999; 150: 399-407
36. Suarez GA, Clark VM, Norell JE, Kottke TE, Callahan MJ, O'Brien PC, Low PA, Dyck PJ. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry 2005; 76: 240-245
37. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circul 1996; 93: 1043-1065
38. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circul 2002; 106: 3143-3421
39. Toyry JP, Niskanen LK, Lansimies EA, Partanen KP, Uusitupa MI. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1996; 27: 1316-1318
40. Valensi P, Paries J, Attali JR. French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications - the French Multicenter Study. Metabolism 2003; 52: 815-820
41. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 2001; 24: 339-343
42. van Huysduynen BH, Swenne CA, Van Eck HJ, Kors JA, Schoneveld AL, Van De Vooren H, Schiereck P, Schalij MJ, Van Der Wall EE. Hypertensive stress increases dispersion of repolarization. Pacing Clin Electrophysiol 2004; 27: 1603-1609
43. Villareal RP, Liu BC, Massumi A. Heart rate variability and cardiovascular mortality. Curr Atheroscler Rep 2002; 4: 120-127
44. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579
45. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE. Detection of ischemia in asymptomatic diabetics investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27: 1954-1961
46. Wang TD, Chen WJ, Chien KL, Seh-Yi Su SS, Hsu HC, Chen MF, Liau CS, Lee YT. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am J Cardiol 2001; 88: 737-743
47. Whitsel EA, Boyko EJ, Siscovick DS. Reassessing the role of QJc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care 2000; 23: 241-247
48. WHO MONICA Project Principal Investigators, prepared by H. Tunstall-Pedoe. The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 1988; 34: 105-114
49. Ziegler D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 1999; 7: 342-357